Sang Kim
0000-0003-0926-1840
University of Texas MD Anderson Cancer Center Children's Cancer Hospital
4 papers found
Refreshing results…
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871
Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis
Missing publications? Search for publications with a matching author name.